BresaGen, Inc.
6Patents
1Active
6Granted
29Portfolio score
Filing activity: Dec 4, 1997 → Jun 18, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6849448B1 | Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene | Chemistry; Metallurgy | 34 | Expired |
| US7737253B2 | Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof | Physics | 16 | Active |
| US6749833B2 | Design and planning system for improving the survival rate of injected structures | Human Necessities | 11 | Expired |
| US7445931B2 | Compositions and methods for enrichment of neural stem cells using ceramide analogs | Chemistry; Metallurgy | 9 | Expired |
| US7201899B2 | Materials and methods for management of hyperacute rejection in human xenotransplantation | Chemistry; Metallurgy | 5 | Expired |
| US6465616B1 | Interleukin-5 antagonist | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.